Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Rohto Pharmaceutical Co ( (JP:4527) ) is now available.
Rohto Pharmaceutical’s board has formally opposed two shareholder proposals submitted ahead of its June 24, 2026 ordinary general meeting, including one calling for the dismissal of director and former president Kunio Yamada. The board argues that director appointments and dismissals must be based on individual contributions to corporate value rather than attributes such as founding-family status or tenure, and says it sees no evidence that Yamada’s continued service has harmed corporate value or shareholder interests.
Management highlights that Yamada has overseen a sharp rise in sales and operating income and driven the company’s evolution into a global player through both organic growth and M&A. The board also notes that director terms are limited to one year, meaning shareholders can effectively judge Yamada’s suitability via his reappointment vote, and stresses that nominations are vetted by a committee dominated by independent outside directors, signaling resistance to activist pressure while emphasizing existing governance processes.
The most recent analyst rating on (JP:4527) stock is a Buy with a Yen2980.00 price target. To see the full list of analyst forecasts on Rohto Pharmaceutical Co stock, see the JP:4527 Stock Forecast page.
More about Rohto Pharmaceutical Co
Rohto Pharmaceutical Co., Ltd. is a Japan-based healthcare company listed on the TSE Prime that develops and markets pharmaceutical and cosmetic products, with a growing focus on global expansion. Under long-time leader Kunio Yamada, it has scaled both sales and operating income severalfold while increasing its overseas sales ratio to above 50%, supported by active M&A in businesses such as DAX Cosmetics, Ophthalmos S.A., and ROHTO NITTEN.
Average Trading Volume: 809,337
Technical Sentiment Signal: Sell
Current Market Cap: Yen537.9B
Learn more about 4527 stock on TipRanks’ Stock Analysis page.